Microarray Analysis Market Research Report - Global Forecast till 2023

Microarray Analysis Market Research Report - Global Forecast till 2023

ID: MRFR/LS/0293-HCRR | September, 2018 | Region: Global | 80 pages | Half-Cooked Research Reports

Microarray Analysis Market Research Report: By Technology (DNA Microarray, PCR, NGS, SAGE, and Northern Blotting), By Consumables (DNA Chips, DNA Microarrays, Protein Microarrays, Cellular Microarrays, Chemical Compound Microarrays, Antibody Microarrays and others), By Services (Gene Profiling and Bioinformatics) and By Applications (Research, Drug Discovery and Diagnostic) - Global Forecast till 2023


Market Scenario


Microarrays is a powerful approach for the analysis of gene expression that can be used for various experimental purposes. Numerous types of microarray platforms are available for testing. Development of microarrays had improved results of genetic testing. The global microarrays analysis market is majorly driven by the increasing prevalence of cancer and rising need of research in pharmaceutical industries. Increasing prevalence of different chronic diseases, use of this techniques for the diagnosis of infectious diseases, development in the field of genetics and increasing healthcare expenditure; all these together have provided a push for this market’s growth. However, high cost of tests and need of high tech instruments may restrain growth of this market.

The global microarray analysis market is expected to grow at a CAGR 9.8% during the forecast period 2017-2023.


Intended Audience



  • Microarray manufacturer

  • Microarray supplier

  • Research & development (R&D) companies

  • Independent research laboratories

  • Market research and consulting service providers

  • Medical research laboratories

  • Academic medical institutes and universities


 


Figure 1- Global Microarray Analysis Market, by Region


Global Microarray Analysis Market


Segmentation
The global microarray analysis market is segmented into technology, consumables, services, application and end users.
 On the basis of technology, the market is segmented into DNA microarray, PCR, NGS, SAGE, northern blotting and others.
On the basis of consumables, the market is segmented into DNA chips, DNA microarrays, protein microarrays, cellular microarrays, chemical compound microarrays, antibody microarrays and others. On the basis of services, the market is divided into gene profiling, bioinformatics and others.
On the basis of applications, the market is categorized into research, drug discovery, diagnostic and others. 



Regional Analysis
America accounts for the largest share in the global microarray analysis market owing to the presence of well-developed healthcare sector and government support for research & development. Europe is the second largest market of global microarray analysis which is followed by Asia Pacific. Presence of large cancer population and increasing need for better diagnostic treatment has driven the European market. Asia Pacific microarray analysis market is majorly occupied by Japan. India and China, these are the growing market of microarray analysis. Middle East & Africa have least share in this market.



Key Players
Among many layers, some of the key player in the market are QIAGEN (Germany), Thermo Fisher Scientific, Inc. (US), Agilent Technologies (US), Applied Micro Arrays (US), Merck Sharp & Dohme Corp (US), Bio-Rad Laboratories, Inc. (US), PerkinElmer Inc. (US), Illumina, Inc. (US), Arrayit Corporation (US), BioGenex (US) and General Electric Company (UK). 



Market Assessment


 


Microarray Analysis Market-


Source- World Health Organization (WHO), white paper, company presentation, annual reports

Table of Contents



1 Introduction

1.1 Definition

1.2 Scope of the Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porters Five Forces Model

4.2 Bargaining Power of Suppliers

4.3 Bargaining Power of Buyers

4.4 Threat of New Entrants

4.5 Threat of Substitutes

4.6 Intensity of Rivalry

5. Global Microarray Analysis Market, By Technology

5.1 DNA microarray

5.2 PCR

5.3 NGS

5.4 SAGE

5.5 Northern blotting

5.6 Others

6. Global Microarray Analysis Market, by Consumables

6.1 DNA chips

6.2 DNA microarrays

6.3 Protein microarrays

6.4 Cellular microarrays

6.5 Chemical compound microarrays

6.6 Antibody microarrays

6.7 Others

7. Global Microarray Analysis Market, by Services

7.1 Gene Profiling

7.2 Bioinformatics

7.3 Others

8. Global Microarray Analysis Market, by Applications

8.1 Research

8.2 Drug Discovery

8.3 Diagnostic

8.4 Others

9. Global Microarray Analysis Market, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

10. Competitive Landscape

10.1 Major Strategies Adopted by Market Players

10.1.1 Strategic Partnership

10.1.2 Merger & Acquisition

11 Company Profile

11.1 QIAGEN

11.1.1 Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 Key Developments

11.2 Thermo Fisher Scientific, Inc.

11.2.1 Overview

11.2.2 Product Overview

11.2.3 Financials

11.2.4 Key Developments

11.3 Agilent Technologies

11.3.1 Overview

11.3.2 Product Overview

11.3.3 Financials

11.3.4 Key Development

11.4 Applied Micro Arrays

11.4.1 Overview

11.4.2 Product Overview

11.4.3 Financials

11.4.4 Key Developments

11.5 Merck Sharp & Dohme Corp

11.5.1 Overview

11.5.2 Product Overview

11.5.3 Financials

11.5.4 Key Developments

11.6 Bio-Rad Laboratories, Inc.

11.6.1 Overview

11.6.2 Product Overview

11.6.3 Financials

11.6.4 Key Developments

11.7 PerkinElmer Inc.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.8 Illumina, Inc.

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Development

11.9 Others

12 Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Diagnostic Industry

13 Appendix